by Gérard Emilien, Cécile Durlach, Kenneth Lloyd Minaker, Bengt Winblad, Serge Gauthier, Jean-Marie Maloteaux.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Basel
Name of Publisher, Distributor, etc.
Birkhäuser Basel : Imprint : Birkhäuser
Date of Publication, Distribution, etc.
2004
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(XXIV, 288 pages)
CONTENTS NOTE
Text of Note
Introduction --;Part I: Biological correlates of Alzheimer disease: Chapter 1: Alzheimer disease. Chapter 2: Neurological dysfunctions in Alzheimer disease. Chapter 3: Pharmacology of Alzheimer disease. Chapter 4: Molecular genetics of Alzheimer disease. Chapter 5: Promises of animal models of Alzheimer disease --;Part II:Neuropsychology of Alzheimer disease: Chapter 6: What is memory? Chapter 7: Mild Cognitive Impairment. Chapter 8: Cognitive impairment in Alzheimer disease. Chapter 9: Behavioral and psychological impairments. Chapter 10: Assessment of memory. Chapter 11: Functional abilities and behavioral symptom assessments --;Part III:Treatment of Alzheimer disease: Chapter 12: Pharmacological treatments of cognitive deficits. Chapter 13: Pharmacological treatment of neuropsychiatric symptoms. Chapter 14: Psychological support and cognitive rehabilitation. Chapter 15: Discussion and conclusion.
SUMMARY OR ABSTRACT
Text of Note
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level.
TOPICAL NAME USED AS SUBJECT
Alzheimer's disease -- Chemotherapy.
Alzheimer's disease.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC523
Book number
.
B944
2004
PERSONAL NAME - PRIMARY RESPONSIBILITY
by Gérard Emilien, Cécile Durlach, Kenneth Lloyd Minaker, Bengt Winblad, Serge Gauthier, Jean-Marie Maloteaux.